Western New York Bloodcare Inc
Western New York Bloodcare Inc shows consistent revenue growth but reported a $4.85 million deficit in 2023.
EIN: 160965865 · Buffalo, NY · NTEE: E32 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $42.7M |
| Total Expenses | $42.2M |
| Program Spending | 85% |
| CEO/Top Officer Pay | $37 |
| Net Assets | $26.9M |
| Transparency Score | 85/100 |
Is Western New York Bloodcare Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Western New York Bloodcare Inc directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Western New York Bloodcare Inc
Western New York Bloodcare Inc (EIN: 160965865) is a nonprofit organization based in Buffalo, NY, classified under NTEE code E32. The organization reported total revenue of $42.7M and total assets of $27.4M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Western New York Bloodcare Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Western New York Bloodcare Inc is a large nonprofit that has been operating for 30 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 8.9%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $37.4M |
| Total Expenses | $42.2M |
| Surplus / Deficit | $-4,851,259 |
| Total Assets | $30.3M |
| Total Liabilities | $3.4M |
| Net Assets | $26.9M |
| Operating Margin | -13.0% |
| Debt-to-Asset Ratio | 11.2% |
| Months of Reserves | 8.6 months |
Financial Health Grade: B
In 2023, Western New York Bloodcare Inc reported a deficit of $4.9M with expenses exceeding revenue, holds 8.6 months of operating reserves (strong position), has a debt-to-asset ratio of 11.2% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Western New York Bloodcare Inc's revenue has grown at a compound annual growth rate (CAGR) of 8.9%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +9.4% | +43.1% | -8.9% |
| 2022 | +13.3% | +10.9% | +10.0% |
| 2021 | +2.1% | -16.7% | +16.3% |
| 2020 | +12.9% | +35.2% | -11.3% |
| 2019 | +16.5% | +20.6% | +18.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1996 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Western New York Bloodcare Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Western New York Bloodcare Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $4.9M, with expenses exceeding revenue.
- Debt-to-asset ratio: 11.2%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, which is unusual for an organization of its size with over $37 million in revenue, suggesting either a highly volunteer-driven leadership or that compensation is categorized differently.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Western New York Bloodcare Inc's IRS 990 filings:
- Significant deficit in 2023 ($4.85 million) after years of positive net income.
- Consistent reporting of 0% officer compensation for a large organization, which may obscure actual executive pay practices.
Strengths
The following positive indicators were identified for Western New York Bloodcare Inc:
- Consistent revenue growth over the past decade, from $14,047,921 in 2014 to $37,381,010 in 2023.
- Strong asset base ($30,311,803 in 2023) significantly exceeding liabilities, indicating financial stability.
- Healthy solvency with assets consistently much higher than liabilities.
Frequently Asked Questions about Western New York Bloodcare Inc
Is Western New York Bloodcare Inc a legitimate charity?
Western New York Bloodcare Inc (EIN: 160965865) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $42.7M. 2 red flags identified. 3 strengths noted. Financial health grade: B.
How does Western New York Bloodcare Inc spend its money?
Western New York Bloodcare Inc directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Western New York Bloodcare Inc tax-deductible?
Western New York Bloodcare Inc is registered as a tax-exempt nonprofit (EIN: 160965865). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Western New York Bloodcare Inc CEO make?
Western New York Bloodcare Inc's highest-compensated officer earns $37 annually. The organization reported $42.7M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Western New York Bloodcare Inc's spending goes to programs?
Western New York Bloodcare Inc directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Western New York Bloodcare Inc compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), Western New York Bloodcare Inc is above average for NTEE category E32 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Western New York Bloodcare Inc located?
Western New York Bloodcare Inc is headquartered in Buffalo, New York and files with the IRS under EIN 160965865. It is classified under NTEE code E32.
How many years of IRS 990 filings does Western New York Bloodcare Inc have?
Western New York Bloodcare Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $42.7M in total revenue.
What caused the significant increase in expenses in 2023, leading to a deficit?
In 2023, expenses were $42,232,269, while revenue was $37,381,010, resulting in a deficit. This contrasts with previous years where revenue generally exceeded expenses, and warrants further investigation into the specific expense categories.
How does Western New York Bloodcare Inc manage executive compensation given the 0% reported officer compensation?
The consistent reporting of 0% officer compensation on the 990 forms for an organization with over $37 million in revenue is atypical. It suggests that either key leadership roles are entirely volunteer-based, or compensation for executives is reported under different categories, such as 'salaries and wages' for non-officer employees, which would require deeper analysis of the full 990 form to understand.
What is the organization's strategy for managing its liabilities, which have fluctuated over the years?
Liabilities have varied, from a low of $1,277,817 in 2015 to a high of $3,385,646 in 2023. While assets significantly outweigh liabilities, understanding the nature of these liabilities and the organization's management strategy is important.
Filing History
IRS 990 filing history for Western New York Bloodcare Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Western New York Bloodcare Inc's revenue has grown by 179.4%, moving from $13.4M to $37.4M. Total assets increased by 61.3% over the same period, from $18.8M to $30.3M. Total functional expenses rose by 190.5%, from $14.5M to $42.2M. In its most recent filing year (2023), Western New York Bloodcare Inc reported a deficit of $4.9M, with expenses exceeding revenue. The organization holds $3.4M in liabilities against $30.3M in assets (debt-to-asset ratio: 11.2%), resulting in net assets of $26.9M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $37.4M | $42.2M | $30.3M | $3.4M | — | — |
| 2022 | $34.2M | $29.5M | $33.3M | $1.9M | — | View 990 |
| 2021 | $30.2M | $26.6M | $30.3M | $2.3M | — | View 990 |
| 2020 | $29.6M | $31.9M | $26.0M | $1.7M | — | — |
| 2019 | $26.2M | $23.6M | $29.3M | $2.9M | — | View 990 |
| 2018 | $22.5M | $19.6M | $24.8M | $1.9M | — | View 990 |
| 2017 | $19.1M | $16.9M | $22.4M | $1.4M | — | — |
| 2016 | $16.9M | $16.1M | $19.6M | $1.3M | — | View 990 |
| 2015 | $15.5M | $14.8M | $18.5M | $1.3M | — | View 990 |
| 2014 | $14.0M | $14.1M | $18.7M | $1.3M | — | View 990 |
| 2013 | $12.8M | $13.0M | $19.0M | $1.3M | — | View 990 |
| 2012 | $11.7M | $12.1M | $18.9M | $1.2M | — | View 990 |
| 2011 | $13.4M | $14.5M | $18.8M | $1.2M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $37.4M, expenses of $42.2M, and assets of $30.3M (revenue +9.4% year-over-year).
- 2022: Revenue of $34.2M, expenses of $29.5M, and assets of $33.3M (revenue +13.3% year-over-year).
- 2021: Revenue of $30.2M, expenses of $26.6M, and assets of $30.3M (revenue +2.1% year-over-year).
- 2020: Revenue of $29.6M, expenses of $31.9M, and assets of $26.0M (revenue +12.9% year-over-year).
- 2019: Revenue of $26.2M, expenses of $23.6M, and assets of $29.3M (revenue +16.5% year-over-year).
- 2018: Revenue of $22.5M, expenses of $19.6M, and assets of $24.8M (revenue +17.9% year-over-year).
- 2017: Revenue of $19.1M, expenses of $16.9M, and assets of $22.4M (revenue +12.7% year-over-year).
- 2016: Revenue of $16.9M, expenses of $16.1M, and assets of $19.6M (revenue +9.3% year-over-year).
- 2015: Revenue of $15.5M, expenses of $14.8M, and assets of $18.5M (revenue +10.3% year-over-year).
- 2014: Revenue of $14.0M, expenses of $14.1M, and assets of $18.7M (revenue +9.6% year-over-year).
- 2013: Revenue of $12.8M, expenses of $13.0M, and assets of $19.0M (revenue +9.8% year-over-year).
- 2012: Revenue of $11.7M, expenses of $12.1M, and assets of $18.9M (revenue -12.8% year-over-year).
- 2011: Revenue of $13.4M, expenses of $14.5M, and assets of $18.8M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Western New York Bloodcare Inc:
Data Sources and Methodology
This transparency report for Western New York Bloodcare Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.